Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Identification of MOSPD2, a novel scaffold for endoplasmic reticulum membrane contact sites.

Di Mattia T, Wilhelm LP, Ikhlef S, Wendling C, Spehner D, Nominé Y, Giordano F, Mathelin C, Drin G, Tomasetto C, Alpy F.

EMBO Rep. 2018 Jul;19(7). pii: e45453. doi: 10.15252/embr.201745453. Epub 2018 Jun 1.

2.

Relationship between the agonist activity of synthetic ligands of TRAIL-R2 and their cell surface binding modes.

Chekkat N, Lombardo CM, Seguin C, Lechner MC, Dufour F, Nominé Y, De Giorgi M, Frisch B, Micheau O, Guichard G, Altschuh D, Fournel S.

Oncotarget. 2018 Feb 17;9(21):15566-15578. doi: 10.18632/oncotarget.24526. eCollection 2018 Mar 20.

3.

Mapping the interactome of HPV E6 and E7 oncoproteins with the ubiquitin-proteasome system.

Poirson J, Biquand E, Straub ML, Cassonnet P, Nominé Y, Jones L, van der Werf S, Travé G, Zanier K, Jacob Y, Demeret C, Masson M.

FEBS J. 2017 Oct;284(19):3171-3201. doi: 10.1111/febs.14193. Epub 2017 Aug 29.

PMID:
28786561
4.

Peptide-Protein Binding Investigated by Far-IR Spectroscopy and Molecular Dynamics Simulations.

Cote Y, Nominé Y, Ramirez J, Hellwig P, Stote RH.

Biophys J. 2017 Jun 20;112(12):2575-2588. doi: 10.1016/j.bpj.2017.05.018.

5.

Antibody Binding Selectivity: Alternative Sets of Antigen Residues Entail High-Affinity Recognition.

Nominé Y, Choulier L, Travé G, Vernet T, Altschuh D.

PLoS One. 2015 Dec 2;10(12):e0143374. doi: 10.1371/journal.pone.0143374. eCollection 2015.

6.

Quantifying domain-ligand affinities and specificities by high-throughput holdup assay.

Vincentelli R, Luck K, Poirson J, Polanowska J, Abdat J, Blémont M, Turchetto J, Iv F, Ricquier K, Straub ML, Forster A, Cassonnet P, Borg JP, Jacob Y, Masson M, Nominé Y, Reboul J, Wolff N, Charbonnier S, Travé G.

Nat Methods. 2015 Aug;12(8):787-93. doi: 10.1038/nmeth.3438. Epub 2015 Jun 8.

7.

Spot peptide arrays and SPR measurements: throughput and quantification in antibody selectivity studies.

Vernet T, Choulier L, Nominé Y, Bellard L, Baltzinger M, Travé G, Altschuh D.

J Mol Recognit. 2015 Oct;28(10):635-44. doi: 10.1002/jmr.2477. Epub 2015 May 11.

PMID:
25960426
8.

Disorder-to-order transition of MAGI-1 PDZ1 C-terminal extension upon peptide binding: thermodynamic and dynamic insights.

Ramírez J, Recht R, Charbonnier S, Ennifar E, Atkinson RA, Travé G, Nominé Y, Kieffer B.

Biochemistry. 2015 Feb 17;54(6):1327-37. doi: 10.1021/bi500845j. Epub 2015 Feb 3.

PMID:
25590897
9.

Reversible amyloid fiber formation in the N terminus of androgen receptor.

Asencio-Hernández J, Ruhlmann C, McEwen A, Eberling P, Nominé Y, Céraline J, Starck JP, Delsuc MA.

Chembiochem. 2014 Nov 3;15(16):2370-3. doi: 10.1002/cbic.201402420. Epub 2014 Sep 11.

PMID:
25212277
10.

Intracellular delivery of functionally active proteins using self-assembling pyridylthiourea-polyethylenimine.

Postupalenko V, Sibler AP, Desplancq D, Nominé Y, Spehner D, Schultz P, Weiss E, Zuber G.

J Control Release. 2014 Mar 28;178:86-94. doi: 10.1016/j.jconrel.2014.01.017. Epub 2014 Jan 27.

PMID:
24476809
11.

The GIP gamma-tubulin complex-associated proteins are involved in nuclear architecture in Arabidopsis thaliana.

Batzenschlager M, Masoud K, Janski N, Houlné G, Herzog E, Evrard JL, Baumberger N, Erhardt M, Nominé Y, Kieffer B, Schmit AC, Chabouté ME.

Front Plant Sci. 2013 Nov 27;4:480. doi: 10.3389/fpls.2013.00480. eCollection 2013.

12.

TRAF4 is a novel phosphoinositide-binding protein modulating tight junctions and favoring cell migration.

Rousseau A, McEwen AG, Poussin-Courmontagne P, Rognan D, Nominé Y, Rio MC, Tomasetto C, Alpy F.

PLoS Biol. 2013 Dec;11(12):e1001726. doi: 10.1371/journal.pbio.1001726. Epub 2013 Dec 3.

13.

Chemical library screening using a SPR-based inhibition in solution assay: simulations and experimental validation.

Choulier L, Nominé Y, Zeder-Lutz G, Charbonnier S, Didier B, Jung ML, Altschuh D.

Anal Chem. 2013 Sep 17;85(18):8787-95. doi: 10.1021/ac4019445. Epub 2013 Aug 30.

PMID:
23931734
14.

Sequence and structure requirements for specific recognition of HIV-1 TAR and DIS RNA by the HIV-1 Vif protein.

Freisz S, Mezher J, Hafirassou L, Wolff P, Nominé Y, Romier C, Dumas P, Ennifar E.

RNA Biol. 2012 Jul;9(7):966-77. doi: 10.4161/rna.20483. Epub 2012 Jul 1.

PMID:
22767258
15.

Putting into practice domain-linear motif interaction predictions for exploration of protein networks.

Luck K, Fournane S, Kieffer B, Masson M, Nominé Y, Travé G.

PLoS One. 2011;6(11):e25376. doi: 10.1371/journal.pone.0025376. Epub 2011 Nov 1.

16.

Proteasomal degradation of p53 by human papillomavirus E6 oncoprotein relies on the structural integrity of p53 core domain.

Bernard X, Robinson P, Nominé Y, Masson M, Charbonnier S, Ramirez-Ramos JR, Deryckere F, Travé G, Orfanoudakis G.

PLoS One. 2011;6(10):e25981. doi: 10.1371/journal.pone.0025981. Epub 2011 Oct 27.

17.

Strategies for bacterial expression of protein-peptide complexes: application to solubilization of papillomavirus E6.

Sidi AO, Babah KO, Brimer N, Nominé Y, Romier C, Kieffer B, Pol SV, Travé G, Zanier K.

Protein Expr Purif. 2011 Nov;80(1):8-16. doi: 10.1016/j.pep.2011.06.013. Epub 2011 Jul 14.

18.

The structural and dynamic response of MAGI-1 PDZ1 with noncanonical domain boundaries to the binding of human papillomavirus E6.

Charbonnier S, Nominé Y, Ramírez J, Luck K, Chapelle A, Stote RH, Travé G, Kieffer B, Atkinson RA.

J Mol Biol. 2011 Mar 11;406(5):745-63. doi: 10.1016/j.jmb.2011.01.015. Epub 2011 Jan 13.

PMID:
21238461
19.

Surface plasmon resonance analysis of the binding of high-risk mucosal HPV E6 oncoproteins to the PDZ1 domain of the tight junction protein MAGI-1.

Fournane S, Charbonnier S, Chapelle A, Kieffer B, Orfanoudakis G, Travé G, Masson M, Nominé Y.

J Mol Recognit. 2011 Jul-Aug;24(4):511-23. doi: 10.1002/jmr.1056. Epub 2010 Sep 14.

PMID:
20842623
20.

Molecular basis for the association of human E4B U box ubiquitin ligase with E2-conjugating enzymes UbcH5c and Ubc4.

Benirschke RC, Thompson JR, Nominé Y, Wasielewski E, Juranić N, Macura S, Hatakeyama S, Nakayama KI, Botuyan MV, Mer G.

Structure. 2010 Aug 11;18(8):955-65. doi: 10.1016/j.str.2010.04.017.

21.

Prevalence of intrinsic disorder in the hepatitis C virus ARFP/Core+1/S protein.

Boumlic A, Nominé Y, Charbonnier S, Dalagiorgou G, Vassilaki N, Kieffer B, Travé G, Mavromara P, Orfanoudakis G.

FEBS J. 2010 Feb;277(3):774-89. doi: 10.1111/j.1742-4658.2009.07527.x. Epub 2010 Jan 7.

22.

Kinetic analysis of interaction of BRCA1 tandem breast cancer c-terminal domains with phosphorylated peptides reveals two binding conformations.

Nominé Y, Botuyan MV, Bajzer Z, Owen WG, Caride AJ, Wasielewski E, Mer G.

Biochemistry. 2008 Sep 16;47(37):9866-79. doi: 10.1021/bi702247d. Epub 2008 Aug 22.

23.

Formation of well-defined soluble aggregates upon fusion to MBP is a generic property of E6 proteins from various human papillomavirus species.

Zanier K, Nominé Y, Charbonnier S, Ruhlmann C, Schultz P, Schweizer J, Travé G.

Protein Expr Purif. 2007 Jan;51(1):59-70. Epub 2006 Sep 9.

PMID:
17055740
24.

Structural and functional analysis of E6 oncoprotein: insights in the molecular pathways of human papillomavirus-mediated pathogenesis.

Nominé Y, Masson M, Charbonnier S, Zanier K, Ristriani T, Deryckère F, Sibler AP, Desplancq D, Atkinson RA, Weiss E, Orfanoudakis G, Kieffer B, Travé G.

Mol Cell. 2006 Mar 3;21(5):665-78.

25.

Kinetic analysis of the interactions of human papillomavirus E6 oncoproteins with the ubiquitin ligase E6AP using surface plasmon resonance.

Zanier K, Charbonnier S, Baltzinger M, Nominé Y, Altschuh D, Travé G.

J Mol Biol. 2005 Jun 3;349(2):401-12. Epub 2005 Apr 9.

PMID:
15890204
26.

1H and 15N resonance assignment, secondary structure and dynamic behaviour of the C-terminal domain of human papillomavirus oncoprotein E6.

Nominé Y, Charbonnier S, Miguet L, Potier N, Van Dorsselaer A, Atkinson RA, Travé G, Kieffer B.

J Biomol NMR. 2005 Feb;31(2):129-41.

PMID:
15772752
27.

Structural basis of BACH1 phosphopeptide recognition by BRCA1 tandem BRCT domains.

Botuyan MV, Nominé Y, Yu X, Juranic N, Macura S, Chen J, Mer G.

Structure. 2004 Jul;12(7):1137-46.

28.

Domain substructure of HPV E6 oncoprotein: biophysical characterization of the E6 C-terminal DNA-binding domain.

Nominé Y, Charbonnier S, Ristriani T, Stier G, Masson M, Cavusoglu N, Van Dorsselaer A, Weiss E, Kieffer B, Travé G.

Biochemistry. 2003 May 6;42(17):4909-17.

PMID:
12718532
29.
30.

Formation of soluble inclusion bodies by hpv e6 oncoprotein fused to maltose-binding protein.

Nominé Y, Ristriani T, Laurent C, Lefèvre JF, Weiss E, Travé G.

Protein Expr Purif. 2001 Oct;23(1):22-32.

PMID:
11570842
31.

A strategy for optimizing the monodispersity of fusion proteins: application to purification of recombinant HPV E6 oncoprotein.

Nominé Y, Ristriani T, Laurent C, Lefèvre JF, Weiss E, Travé G.

Protein Eng. 2001 Apr;14(4):297-305.

PMID:
11391022
32.

Specific recognition of four-way DNA junctions by the C-terminal zinc-binding domain of HPV oncoprotein E6.

Ristriani T, Nominé Y, Masson M, Weiss E, Travé G.

J Mol Biol. 2001 Jan 26;305(4):729-39.

PMID:
11162088
33.

HPV oncoprotein E6 is a structure-dependent DNA-binding protein that recognizes four-way junctions.

Ristriani T, Masson M, Nominé Y, Laurent C, Lefevre JF, Weiss E, Travé G.

J Mol Biol. 2000 Mar 10;296(5):1189-203.

PMID:
10698626

Supplemental Content

Loading ...
Support Center